药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfamerazine
Magnesium citrate
The risk or severity of adverse effects can be increased when Magnesium citrate is combined with Sodium phosphate, dibasic.
Sulfamerazine
Methylcellulose
The risk or severity of adverse effects can be increased when Methylcellulose is combined with Sodium phosphate, dibasic.
Sulfamerazine
Docusate
The risk or severity of adverse effects can be increased when Docusate is combined with Sodium phosphate, dibasic.
Sulfamerazine
Mineral oil
The risk or severity of adverse effects can be increased when Mineral oil is combined with Sodium phosphate, dibasic.
Sulfamerazine
Lactitol
The risk or severity of adverse effects can be increased when Lactitol is combined with Sodium phosphate, dibasic.
Sulfamerazine
Sennosides
The risk or severity of adverse effects can be increased when Sennosides is combined with Sodium phosphate, dibasic.
Sulfamerazine
Castor oil
The risk or severity of adverse effects can be increased when Castor oil is combined with Sodium phosphate, dibasic.
Sulfamerazine
Plantago seed
The risk or severity of adverse effects can be increased when Plantago seed is combined with Sodium phosphate, dibasic.
Sulfamerazine
Carboxymethylcellulose
The risk or severity of adverse effects can be increased when Carboxymethylcellulose is combined with Sodium phosphate, dibasic.
Sulfamerazine
Polycarbophil
The risk or severity of adverse effects can be increased when Polycarbophil is combined with Sodium phosphate, dibasic.
Sulfamerazine
Picosulfuric acid
The risk or severity of adverse effects can be increased when Picosulfuric acid is combined with Sodium phosphate, dibasic.
Sulfamerazine
Bisacodyl
The risk or severity of adverse effects can be increased when Bisacodyl is combined with Sodium phosphate, dibasic.
Sulfamerazine
Oxyphenisatin
The risk or severity of adverse effects can be increased when Oxyphenisatin is combined with Sodium phosphate, dibasic.
Sulfamerazine
Dantron
The risk or severity of adverse effects can be increased when Dantron is combined with Sodium phosphate, dibasic.
Sulfamerazine
Sorbitol
The risk or severity of adverse effects can be increased when Sorbitol is combined with Sodium phosphate, dibasic.
Sulfamerazine
Alcuronium
The therapeutic efficacy of Sodium phosphate, dibasic can be decreased when used in combination with Alcuronium.
Sulfamerazine
Gallamine
The therapeutic efficacy of Sodium phosphate, dibasic can be decreased when used in combination with Gallamine.
Sulfamerazine
Atracurium
The therapeutic efficacy of Sodium phosphate, dibasic can be decreased when used in combination with Atracurium.
Sulfamerazine
Hexamethonium
The therapeutic efficacy of Sodium phosphate, dibasic can be decreased when used in combination with Hexamethonium.
Sulfamerazine
Gantacurium
The therapeutic efficacy of Sodium phosphate, dibasic can be decreased when used in combination with Gantacurium.